ANDROGEN RECEPTOR VARIANT-BASED PROSTATE CANCER PATIENT SCREENING METHOD

According to an embodiment of the present invention, a prostate cancer patient screening method is provided, wherein whether AR-targeted therapy is applicable to a prostate cancer patient can be analyzed through optical image analysis of blood-borne circulating tumor cells and AR variants. Selon un...

Full description

Saved in:
Bibliographic Details
Main Author JEON, Byung Hee
Format Patent
LanguageEnglish
French
Korean
Published 11.04.2019
Subjects
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:According to an embodiment of the present invention, a prostate cancer patient screening method is provided, wherein whether AR-targeted therapy is applicable to a prostate cancer patient can be analyzed through optical image analysis of blood-borne circulating tumor cells and AR variants. Selon un mode de réalisation de la présente invention, celle-ci concerne un procédé de dépistage de patient atteint d'un cancer de la prostate, dans lequel l'analyse de la possibilité d'appliquer une thérapie ciblée sur le récepteur des androgènes (AR) à un patient atteint d'un cancer de la prostate est réalisée par l'analyse d'images optiques de cellules tumorales circulantes diffusées par le sang et de variants d'AR. 본 발명의 일실시예에 따르면, 혈중 순환 암세포 및 AR변이체의 광학 이미지 분석을 통해서 전립선암환자에 AR 표적 치료가 적용되는지 여부를 분석할 수 있는 전립선암환자 스크리닝 방법을 제공한다.
Bibliography:Application Number: WO2018KR08047